Clinical Trials Browser

Phase 1 × Interventional × PHY 906 × Clear all

NCT01666756 2021-01-27

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular